company background image
VERO logo

Venus Concept NasdaqCM:VERO Stock Report

Last Price

US$0.35

Market Cap

US$2.6m

7D

-1.8%

1Y

-70.9%

Updated

30 Jan, 2025

Data

Company Financials +

VERO Stock Overview

A medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. More details

VERO fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Venus Concept Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Venus Concept
Historical stock prices
Current Share PriceUS$0.35
52 Week HighUS$2.22
52 Week LowUS$0.28
Beta0.47
1 Month Change-6.48%
3 Month Change-18.12%
1 Year Change-70.90%
3 Year Change-98.39%
5 Year Change-99.67%
Change since IPO-99.55%

Recent News & Updates

Recent updates

It's A Story Of Risk Vs Reward With Venus Concept Inc. (NASDAQ:VERO)

Aug 29
It's A Story Of Risk Vs Reward With Venus Concept Inc. (NASDAQ:VERO)

Would Venus Concept (NASDAQ:VERO) Be Better Off With Less Debt?

May 12
Would Venus Concept (NASDAQ:VERO) Be Better Off With Less Debt?

Some Venus Concept Inc. (NASDAQ:VERO) Analysts Just Made A Major Cut To Next Year's Estimates

Mar 29
Some Venus Concept Inc. (NASDAQ:VERO) Analysts Just Made A Major Cut To Next Year's Estimates

Shareholder Returns

VEROUS Medical EquipmentUS Market
7D-1.8%1.0%-0.5%
1Y-70.9%14.4%24.3%

Return vs Industry: VERO underperformed the US Medical Equipment industry which returned 15% over the past year.

Return vs Market: VERO underperformed the US Market which returned 25.2% over the past year.

Price Volatility

Is VERO's price volatile compared to industry and market?
VERO volatility
VERO Average Weekly Movement12.9%
Medical Equipment Industry Average Movement8.8%
Market Average Movement6.5%
10% most volatile stocks in US Market18.8%
10% least volatile stocks in US Market3.3%

Stable Share Price: VERO's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: VERO's weekly volatility has decreased from 23% to 13% over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
n/a304Rajiv Kanishka De Silvawww.venus.ai

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system.

Venus Concept Inc. Fundamentals Summary

How do Venus Concept's earnings and revenue compare to its market cap?
VERO fundamental statistics
Market capUS$2.60m
Earnings (TTM)-US$50.15m
Revenue (TTM)US$67.20m

0.0x

P/S Ratio

-0.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VERO income statement (TTM)
RevenueUS$67.20m
Cost of RevenueUS$21.72m
Gross ProfitUS$45.48m
Other ExpensesUS$95.63m
Earnings-US$50.15m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-6.91
Gross Margin67.68%
Net Profit Margin-74.62%
Debt/Equity Ratio325.7%

How did VERO perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/30 07:45
End of Day Share Price 2025/01/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Venus Concept Inc. is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael GormanBTIG
Marie ThibaultBTIG
Jeffrey CohenLadenburg Thalmann & Company